Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedA sitewide banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.7%

- Check12 days agoChange DetectedThe site footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe ClinicalTrials.gov site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check40 days agoChange DetectedThe study record history now includes a new revision entry (v3.7.0). The previous revision (v3.6.6) is removed from the visible history, updating the page's change log.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page history now shows a new release entry: Revision: v3.6.6, replacing the previous v3.6.5. This indicates a system update to the ClinicalTrials.gov interface rather than changes to trial data.SummaryDifference0.1%

- Check83 days agoChange DetectedThe record history now includes a new revision entry labeled v3.6.5, replacing the previous v3.6.4, indicating an updated release of the study record metadata.SummaryDifference0.1%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.